Dunhill Financial, LLC Astrazeneca PLC Transaction History
Dunhill Financial, LLC
- $215 Billion
- Q4 2024
A detailed history of Dunhill Financial, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Dunhill Financial, LLC holds 128 shares of AZN stock, worth $9,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128
Previous 64
100.0%
Holding current value
$9,920
Previous $4.99 Million
68.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,366Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.68 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.18 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.91 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.87 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.86 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...